Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Galapagos NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GLPG
Nasdaq
2836
www.glpg.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Galapagos NV
Owning 37% shares,institutional owners seem interested in Galapagos NV (AMS:GLPG),
- Jun 16th, 2025 10:22 pm
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
- Jun 12th, 2025 2:01 pm
Galapagos Creates New Subscription Right Plan
- May 27th, 2025 2:33 pm
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
- May 14th, 2025 2:01 pm
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
- May 12th, 2025 11:36 pm
Galapagos First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
- Apr 26th, 2025 12:32 am
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
- Apr 23rd, 2025 2:01 pm
Galapagos Announces Executive Leadership Updates
- Apr 21st, 2025 2:10 pm
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
- Apr 14th, 2025 11:30 pm
Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
- Apr 11th, 2025 1:05 pm
Biotech stocks slide as Marks resignation seen being negative for sector
- Apr 1st, 2025 9:50 am
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting
- Mar 27th, 2025 2:01 pm
Galapagos to Present at Upcoming Investor Conferences
- Feb 24th, 2025 2:01 pm
Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89%
- Feb 18th, 2025 1:22 am
Galapagos receives transparency notification and 13D filing from Tang Capital
- Feb 17th, 2025 2:01 pm
Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience
- Feb 14th, 2025 12:09 am
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
- Feb 12th, 2025 2:01 pm
Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now
- Feb 12th, 2025 6:03 am
Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Feb 5th, 2025 7:35 am
Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%
- Jan 8th, 2025 5:16 am
Scroll